Quick Answer
Emmaus Life Sciences, Inc. reported Gross Profit of $11.60 million for fiscal year 2025.
Emmaus Life Sciences, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $11.60M | -25.0% |
| 2024 | $15.45M | -45.3% |
| 2023 | $28.25M | +78.8% |
| 2022 | $15.80M | -8.6% |
| 2021 | $17.30M | -17.3% |
| 2020 | $20.92M | -3.4% |
| 2019 | $21.66M | +40.0% |
| 2018 | $15.47M | +3068.6% |
| 2018 | $488.1K | +550.8% |
| 2017 | $75.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.13M | -38.4% | +17.4% |
| June 30, 2025 | $2.67M | -48.1% | +22.3% |
| March 31, 2025 | $2.18M | -3.0% | -57.1% |
| September 30, 2024 | $5.08M | +5.8% | -1.0% |
| June 30, 2024 | $5.14M | -49.9% | +128.4% |
| March 31, 2024 | $2.25M | -64.4% | -53.2% |
| September 30, 2023 | $4.80M | +9.2% | -53.1% |
| June 30, 2023 | $10.25M | +163.5% | +62.1% |
- Emmaus Life Sciences, Inc. showed a decrease of -25.0% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2025 period, Emmaus Life Sciences, Inc.’s gross profit has grown by 15361.3% (from $75.0 thousand to $11.60 million).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: